IRIS
TURNATURI, RITA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.141
EU - Europa 2.666
AS - Asia 2.291
AF - Africa 431
SA - Sud America 382
Continente sconosciuto - Info sul continente non disponibili 270
OC - Oceania 6
Totale 11.187
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.981
SG - Singapore 1.088
IT - Italia 953
RU - Federazione Russa 783
CN - Cina 621
BR - Brasile 314
IE - Irlanda 233
CI - Costa d'Avorio 232
VN - Vietnam 169
DE - Germania 136
FR - Francia 124
UA - Ucraina 117
KR - Corea 108
CA - Canada 105
GB - Regno Unito 80
SN - Senegal 79
NG - Nigeria 50
IN - India 46
SE - Svezia 43
ES - Italia 41
JP - Giappone 40
HK - Hong Kong 38
BD - Bangladesh 37
FI - Finlandia 29
PL - Polonia 28
MX - Messico 25
IQ - Iraq 24
NL - Olanda 24
ZA - Sudafrica 22
ID - Indonesia 21
TR - Turchia 21
AR - Argentina 20
BE - Belgio 15
KE - Kenya 13
UZ - Uzbekistan 12
CZ - Repubblica Ceca 11
VE - Venezuela 11
LT - Lituania 10
AE - Emirati Arabi Uniti 9
BJ - Benin 9
CL - Cile 9
EC - Ecuador 9
JM - Giamaica 9
PK - Pakistan 9
AT - Austria 8
CO - Colombia 8
CR - Costa Rica 8
TN - Tunisia 8
EG - Egitto 7
LB - Libano 7
AU - Australia 6
GR - Grecia 6
HU - Ungheria 6
SA - Arabia Saudita 6
MA - Marocco 5
PY - Paraguay 5
AZ - Azerbaigian 4
IL - Israele 4
TH - Thailandia 4
BG - Bulgaria 3
HR - Croazia 3
IR - Iran 3
MY - Malesia 3
OM - Oman 3
TT - Trinidad e Tobago 3
AL - Albania 2
BB - Barbados 2
CH - Svizzera 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
ET - Etiopia 2
JO - Giordania 2
KZ - Kazakistan 2
LV - Lettonia 2
NP - Nepal 2
PE - Perù 2
PH - Filippine 2
PS - Palestinian Territory 2
SV - El Salvador 2
UY - Uruguay 2
BH - Bahrain 1
BO - Bolivia 1
DK - Danimarca 1
EE - Estonia 1
EU - Europa 1
GA - Gabon 1
GE - Georgia 1
HN - Honduras 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LY - Libia 1
NI - Nicaragua 1
NO - Norvegia 1
PT - Portogallo 1
RS - Serbia 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SR - Suriname 1
VC - Saint Vincent e Grenadine 1
VG - Isole Vergini Britanniche 1
Totale 10.918
Salva come PNG Salva come JPEG
Città #
Dallas 689
Singapore 644
Santa Clara 521
Houston 490
Chandler 451
San Jose 372
Moscow 339
Ashburn 298
Catania 252
Abidjan 232
Chicago 231
Dublin 231
Hefei 135
Council Bluffs 121
Beijing 118
Boardman 115
Seoul 108
Los Angeles 92
Jacksonville 86
Dakar 79
Civitanova Marche 70
Lauterbourg 70
Bremen 62
Andover 61
Cambridge 60
Lawrence 60
Nanjing 57
New York 55
Rome 43
Naples 42
Buffalo 41
Ho Chi Minh City 41
Toronto 38
São Paulo 36
The Dalles 35
Columbus 34
Hong Kong 34
Des Moines 33
Hanoi 31
Tokyo 31
Lagos 28
Wilmington 28
Munich 26
Phoenix 25
Montreal 24
Denver 23
Messina 21
Warsaw 21
Atlanta 18
London 18
Orem 18
San Giovanni la Punta 18
Brooklyn 17
Johannesburg 16
Shenyang 16
Abuja 15
Amsterdam 14
Brussels 14
Da Nang 14
Madrid 14
Saint Petersburg 14
Bari 13
Changsha 13
Dong Ket 13
Jakarta 13
Milan 13
Frankfurt am Main 12
Jiaxing 12
Paternò 12
Poplar 12
Salerno 12
Seattle 12
Baghdad 11
San Mateo 11
Falls Church 10
Helsinki 10
Nanchang 10
Ottawa 10
Pune 10
San Francisco 10
Turku 10
Boston 9
Chennai 9
Cotonou 9
Haiphong 9
Lappeenranta 9
Mexico City 9
Rimini 9
Shanghai 9
Tianjin 9
Washington 9
Belo Horizonte 8
Bologna 8
Brasília 8
Fortaleza 8
Grafing 8
Marseille 8
Paris 8
Pozzallo 8
Rio de Janeiro 8
Totale 7.331
Salva come PNG Salva come JPEG
Nome #
Simultaneous targeting of MOR/DOR: A useful strategy for inflammatory pain modulation 414
((2S)-N-2-methoxy-2-phenylethyl-6,7-benzomorphan compound (2S-LP2): Discovery of a biased mu/delta opioid receptor agonist 326
Neuroprotective effects of Rosmarinus officinalis L. extract in oxygen glucose deprivation (OGD)-injured human neural-like cells 209
Design, synthesis, in vitro evaluation, and molecular modeling studies of N-substituted benzomorphans, analogs of LP2, as novel MOR ligands 199
Benzomorphan skeleton, a versatile scaffold for different targets: A comprehensive review 191
(+)-and (−)-Phenazocine enantiomers: evaluation of their dual opioid agonist/σ1 antagonist properties and antinociceptive effects 191
A new Sigma-1 Receptor antagonist in Chronic Pain Treatment: (+)-2R/S-LP2 effects in inflammatory and neuropathic pain 179
Progress in the development of selective heme oxygenase-1 inhibitors and their potential therapeutic application 174
ANTIALLODINIC AND ANTIHYPERALGESIC EFFECTS OF LP1, AN OPIOID MULTITARGET LIGAND, IN INFLAMMATORY AND NEUROPATHIC PAIN STATES 170
A structure-and ligand-based virtual screening of a database of “small” marine natural products for the identification of “blue” sigma-2 receptor ligands 169
R- ed S-LP2: sintesi, molecular docking e valutazione farmacologica 168
Haloperidol Metabolite II Valproate Ester (S)-(-)-MRJF22: Preliminary Studies as a Potential Multifunctional Agent Against Uveal Melanoma 164
Antinociceptive profile of LP1, a non-peptide multitarget opioid ligand. 162
Benzomorphan scaffold for opioid analgesics and pharmacological tools development: A comprehensive review 162
Exploiting the Power of Stereochemistry in Drug Action: 3-[(2S,6S,11S)-8-Hydroxy-6,11-dimethyl-1,4,5,6-tetrahydro-2,6-methano-3-benzazocin-3(2H)-yl]-N-phenylpropanamide as Potent Sigma-1 Receptor Antagonist 160
Dual MOR/DOR agonist benzomorphan-based compounds for pain relief 158
In Vitro Antioxidant Activity and In Vivo Topical Efficacy of Lipid Nanoparticles Co-Loading Idebenone and Tocopheryl Acetate 155
Influenza del N-sostituente della (–)-cis-N-Normetazocina nella modulazione del profilo funzionale al MOR, DOR e KOR: da agonista ad antagonista attraverso ligandi misti agonisti/antagonisti 155
Intercellular communication and ion channels in neuropathic pain chronicization 154
THE BENZOMORPHAN-BASED COMPOUND LP1 AS A MULTITARGET OPIOID LIGAND FOR CHRONIC PAIN TREATMENT 152
Design, synthesis and biological evaluation of novel aminopropylcarboxamide derivatives as sigma ligands 151
Sigma-1 Receptor Inhibition Reduces Mechanical Allodynia and Modulate Neuroinflammation in Chronic Neuropathic Pain 149
CO2-derived non-isocyanate polyurethanes (NIPUs) and their potential applications 148
Development of novel LP1-based analogues with enhanced delta opioid receptor profile 148
Novel N-Substituted Benzomorphan-Based Compounds: From MOR-Agonist/DOR-Antagonist to Biased/Unbiased MOR Agonists 146
Antiproliferative and Antioxidant Activity of Glycoconjugates of Dithiocarbamates and Their Copper(II) and Zinc(II) Complexes 145
The Multimodal MOPr/DOPr Agonist LP2 Reduces Allodynia in Chronic Constriction Injured Rats by Rescue of TGF-β1 Signalling 145
Dual Sigma-1 receptor antagonists and hydrogen sulfide-releasing compounds for pain treatment: Design, synthesis, and pharmacological evaluation 145
Biotin-8-hydroxyquinoline conjugates and their metal complexes: Exploring the chemical properties and the antioxidant activity 144
Dual-target ligands and pain: our experience 143
The benzomorphan-based compound LP1 is a central acting MOR agonist/DOR antagonist suitable for chronic pain treatment 142
MOR/DOR targeting: an useful strategy in pain management 142
Nitric Oxide Photo-Donor Hybrids of Ciprofloxacin and Norfloxacin: A Shift in Activity from Antimicrobial to Anticancer Agents 142
Design and synthesis of trans-decahydroisoquinoline derivatives as new tramadol-like ligands 140
Simultaneous Activation of Mu and Delta Opioid Receptors Reduces Allodynia and Astrocytic Connexin 43 in an Animal Model of Neuropathic Pain 139
Synthesis, in vitro and in vivo characterization of new benzoxazole and benzothiazole-based sigma receptor ligands 139
From plant to bench: natural products as source for analgesic drug development. 138
Synthesis and Structure-Activity Relationships of LP1 Derivatives: N-Methyl-N-phenylethylamino Analogues as Novel MOR Agonists 137
New selective Sigma-1/HDACi prodrugs for neurodegenerative disorders 136
LP2 e 2S-LP2: agonisti biased dual target MOR/DOR nel trattamento del dolore cronico 135
Correction to Nitric Oxide Photo-Donor Hybrids of Ciprofloxacin and Norfloxacin: A Shift in Activity from Antimicrobial to Anticancer Agents 134
Design, synthesis, and biological evaluation of new hybrid MOR agonist/HDACi compounds: an innovative approach for persistent pain management 133
Mu and Delta Opioid Receptor Targeting Reduces Connexin 43-Based Heterocellular Coupling during Neuropathic Pain 131
Multitarget Opioid/Non-opioid Ligands: A Potential Approach in Pain Management 130
Targeting heme Oxygenase-1 with hybrid compounds to overcome Imatinib resistance in chronic myeloid leukemia cell lines 128
Novel N-normetazocine Derivatives with Opioid Agonist/Sigma-1 Receptor Antagonist Profile as Potential Analgesics in Inflammatory Pain 127
Repeated activation of delta opiod receptors counteracts nerve injury-induced TNF-α up-regulation in the sciatic nerve of rats with neuropathic pain: A possible correlation with delta opiod receptors-mediated antiallodinic effect. 127
Analgesici oppioidi 126
From Plant to Chemistry: Sources of Antinociceptive Non-Opioid Active Principles for Medicinal Chemistry and Drug Design 122
Design, Synthesis and biological evaluation of hybrid MOR agonist/ HDACi molecules as potential therapeutic agents for chronic pain treatment 122
The benzomorphan-based LP1 ligand is a suitable MOR/DOR agonist for chronic pain treatment 121
New Insights into the Opioid Analgesic Profile of cis-(-)-N-Normetazocine-derived Ligands 119
Design, synthesis and biological evaluation of MOR agonist/HDACi hybrid compounds: a new potential therapeutic strategy for persistent pain management 119
Multitarget opioid ligands in pain relief: New players in an old game 118
Evaluation of N-substituent structural variations in opioid receptor profile of LP1. 116
The multitarget opioid ligand LP1's effects in persistent pain and in primary cell neuronal cultures 113
Progress in the development of more effective and safer analgesics for pain management 112
Efficient green solvent-free CO2/epoxide cycloaddition catalyzed by a β-cyclodextrin-imidazolium-based ionic liquid 111
Tuning Properties for Blood-Brain Barrier Permeation: A Statistics-Based Analysis 111
Differential scanning calorimetry approach to investigate the transfer of the multitarget opioid analgesic LP1 to biomembrane model 110
Sigma Receptor Ligands Carrying a Nitric Oxide Donor Nitrate Moiety: Synthesis, In Silico, and Biological Evaluation 110
Idebenone: Novel strategies to improve its systemic and local efficacy 108
The Benzomorphan-Based Compound LP1 as Suitable Candidate for Pain Management 108
Hybrid MOR agonist/HDACi molecules as potential antinociceptive multi-target drugs: design, synthesis, and biological evaluation 107
From agonist to antagonist profile in LP1 analogues through the introduction of different N-substituents in benzomorphan-based ligands 105
Rosemary Essential Oil-Loaded Lipid Nanoparticles: In Vivo Topical Activity from Gel Vehicles 104
Tetrazine–trans-cyclooctene ligation: Unveiling the chemistry and applications within the human body 102
Novel N-normetazocine Derivatives with Opioid Agonist/Sigma-1 Receptor Antagonist Profile as Potential Analgesics for Pain Treatment 101
Synthesis and structure-activity relationships of (–)-cis-N-normetazocine-based LP1 derivatives 99
Simultaneous activation of mu and delta opioid receptors reduces allodynia and astrocytic connexin 43 in an animal model of neuropathic pain 96
Modulation of opioid receptor profile of LP1 analogues through the introduction of different N-substituents 93
Hybrid MOR agonist/HDACi molecules as potential new drugs for persistant pain management: design, synthesis and biological evaluation 91
MOR/DOR Dual-Target Approach: 2S-LP2 Effects in Inflammatory and Neuropathic Pain 91
NEW PLAYERS IN AN OLD GAME: Pharmacological Evaluation of the Benzomorphan-Based Compound LP1. Design and Synthesis of Conformationally Constrained Compounds as New Tramadol-like Candidates. 90
Resveratrol-loaded lipid nanocarriers: Correlation between in vitro occlusion factor and in vivo skin hydrating effect 89
Multitarget MOR/DOR antinociceptive ligands as useful profile in pain management: synthesis and pharmacological studies of 6,7-benzomorphan-based LP2 and its isomers 89
IDEBENONE LOADED LIPID NANOPARTICLES: EVALUATION OF IN VITRO ANTIOXIDANT ACTIVITY AND IN VIVO TOPICAL EFFECTS 88
Solid lipid nanoparticles as carriers for the synthetic opioid lp2: Characterization and in vitro release 87
In Vitro Evaluation of Sunscreen Safety: Effects of the Vehicle and Repeated Applications on Skin Permeation from Topical Formulations 80
THE BENZOMORPHAN-BASED LP1 IS A CENTRAL-ACTING MULTITARGET OPIOID LIGAND FOR CHRONIC PAIN TREATMENT 78
Synthesis and structure-activity relationships of (-)-cis-N-Normetazocine-based LP1 derivatives 73
NEW BENZOMORPHAN-BASED LP1 LIGAND AS SUITABLE MIXED MOP/DOP RECEPTORS AGONIST FOR CHRONIC PAIN TREATMENT 69
Discovery of a novel series of potent carbonic anhydrase inhibitors with selective affinity for μ Opioid receptor for Safer and long-lasting analgesia 33
Totale 11.187
Salva come PNG Salva come JPEG
Categoria #
all - tutte 34.468
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.468
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022433 0 0 0 17 82 10 73 24 41 24 20 142
2022/20231.239 90 79 32 192 96 165 7 244 220 30 52 32
2023/2024721 33 102 43 32 53 193 35 55 2 23 106 44
2024/20252.298 53 340 113 188 442 307 187 97 125 143 150 153
2025/20264.546 313 225 817 271 645 921 449 98 259 285 136 127
2026/2027478 204 160 93 21 0 0 0 0 0 0 0 0
Totale 11.187